-
Taxonomy & unit
-
ifrs-full: USD
-
Summary
-
RedHill Biopharma Ltd. annual/quarterly Research And Development Expense history and growth rate from Q2 2017 to Q2 2022.
- RedHill Biopharma Ltd. Research And Development Expense for the quarter ending June 30, 2022 was $1.47M, a 85.7% decline year-over-year.
- RedHill Biopharma Ltd. annual Research And Development Expense for 2023 was $3.53M, a 51.5% decline from 2022.
- RedHill Biopharma Ltd. annual Research And Development Expense for 2022 was $7.28M, a 75.3% decline from 2021.
- RedHill Biopharma Ltd. annual Research And Development Expense for 2021 was $29.5M, a 78.9% increase from 2020.
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Growth (%)